Pricing Log in Create free account

Fractyl Health, Inc. (GUTS) vs Vyome Holdings, Inc. (HIND)

Fractyl Health, Inc. and Vyome Holdings, Inc. are both Biotechnology companies. Fractyl Health, Inc. and Vyome Holdings, Inc. are of similar size ($11.9M and $11.4M). Fractyl Health, Inc. grew revenue faster over the last twelve months: −22.5% against −67.1%. Fractyl Health, Inc. has the higher net margin (0.00% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Vyome Holdings, Inc. leads on 8 and Fractyl Health, Inc. on 7.

Valuation

Metric GUTS HIND Biotechnology median
P/E n/m n/m 10.26
P/S 127.89 87.06 9.18
P/B n/m 1.55 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.06 n/m 0.65
EV/Sales (51.61) 124.58 8.98
Earnings yield (1,173.80%) (222.25%) (34.89%)
Free cash flow yield (697.71%) (49.36%) (24.52%)

Profitability

Metric GUTS HIND Biotechnology median
Gross margin 46.24% 52.77% 65.16%
Operating margin 0.00% (9,184.82%) 0.00%
Net margin 0.00% (8,711.71%) 0.00%
Free cash flow margin 0.00% (4,298.00%) 0.00%
Return on equity 1,063.04% (172.10%) (50.12%)
Return on assets (146.75%) (124.23%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS HIND Biotechnology median
Revenue growth (TTM) (22.50%) (67.10%) 6.26%
EPS growth (last fiscal year) (14.81%) 99.92% 29.88%
Revenue growth, 5-year CAGR — (50.98%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GUTS HIND Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 4.37 4.89
Net debt to EBITDA 0.53 0.48 1.01

Dividend

Metric GUTS HIND Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GUTS HIND Biotechnology median
Market cap 11.88m 11.44m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack